Dr. Matthew is a doctoral-level neuroscientist and federal research program strategist with more than 20 years of experience spanning translational neuroscience, large-scale federal research portfolio management, scientific peer review leadership, and grants administration. He brings rare insight into how federally funded medical research programs are structured, evaluated, and successfully executed thorugh many years as a Scientific Review Manager.

As a member of the ScienceDocs Research Strategy Council, Dr. Matthew advises universities, research institutions, startups, and principal investigators on how to align scientific innovation with federal priorities, peer review expectations, and long-term portfolio strategy. His expertise is especially valuable for organizations seeking to strengthen competitiveness in Department of Defense (DoD), NIH, and other federally sponsored programs.

As a former Scientific Review Manager, Dr. Matthew previously managed a $107 million federally funded medical research portfolio, overseeing multiple peer review programs focused on ALS, spinal cord injury, Alzheimer’s disease, epilepsy, and related neurological and behavioral health conditions. Serving as a primary liaison to federal agency clients, he directed integrated peer review processes, coordinated scientific review panels composed of leading clinicians and researchers, and ensured 100% on-time, within-budget delivery of program reports and summary statements.

His background provides deep understanding of:

• Federal peer review mechanics

• Proposal evaluation criteria and scoring dynamics

• Programmatic alignment and portfolio balance

• Compliance, reporting, and award lifecycle management

• Stakeholder coordination across government, academia, and research consortia

Scientifically, Dr. Matthew completed postdoctoral training in neuroscience and earned a Ph.D. in psychology/neuroscience. His research career includes more than 27 peer-reviewed publications, book chapters, federally funded awards, and thousands of research citations. His translational research has focused on neurobiology, addiction and relapse, sex differences in drug response, neurodegenerative disease models, and behavioral health.

In addition to federal program leadership, Dr. Matthew supports SBIR/STTR applicants and academic investigators by strengthening research strategy, refining technical aims, improving experimental design, and ensuring alignment between innovation claims and reviewer expectations. He is particularly effective at identifying structural weaknesses in proposals before submission and transforming technically strong ideas into strategically competitive applications.

Dr. Matthew’s integrated perspective — combining bench science, federal review leadership, portfolio oversight, and program execution — makes him a powerful strategic asset for institutions seeking to compete at the highest levels of federal research funding.

To work with Dr. Matthew, please request him HERE.